STERIS Gross Profit 2010-2024 | STE
STERIS annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- STERIS gross profit for the quarter ending September 30, 2024 was $0.579B, a 5.96% increase year-over-year.
- STERIS gross profit for the twelve months ending September 30, 2024 was $2.294B, a 14.37% increase year-over-year.
- STERIS annual gross profit for 2024 was $2.218B, a 11.99% increase from 2023.
- STERIS annual gross profit for 2023 was $1.981B, a 5.19% increase from 2022.
- STERIS annual gross profit for 2022 was $1.883B, a 40.2% increase from 2021.
| STERIS Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $2,218 |
| 2023 | $1,981 |
| 2022 | $1,883 |
| 2021 | $1,343 |
| 2020 | $1,320 |
| 2019 | $1,175 |
| 2018 | $1,093 |
| 2017 | $1,026 |
| 2016 | $895 |
| 2015 | $774 |
| 2014 | $650 |
| 2013 | $621 |
| 2012 | $568 |
| 2011 | $446 |
| 2010 | $539 |
| 2009 | $527 |
| STERIS Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $579 |
| 2024-06-30 | $572 |
| 2024-03-31 | $540 |
| 2023-12-31 | $603 |
| 2023-09-30 | $546 |
| 2023-06-30 | $529 |
| 2023-03-31 | $409 |
| 2022-12-31 | $521 |
| 2022-09-30 | $532 |
| 2022-06-30 | $518 |
| 2022-03-31 | $438 |
| 2021-12-31 | $538 |
| 2021-09-30 | $480 |
| 2021-06-30 | $426 |
| 2021-03-31 | $380 |
| 2020-12-31 | $346 |
| 2020-09-30 | $330 |
| 2020-06-30 | $287 |
| 2020-03-31 | $364 |
| 2019-12-31 | $331 |
| 2019-09-30 | $319 |
| 2019-06-30 | $306 |
| 2019-03-31 | $334 |
| 2018-12-31 | $287 |
| 2018-09-30 | $285 |
| 2018-06-30 | $269 |
| 2018-03-31 | $292 |
| 2017-12-31 | $278 |
| 2017-09-30 | $266 |
| 2017-06-30 | $256 |
| 2017-03-31 | $281 |
| 2016-12-31 | $258 |
| 2016-09-30 | $248 |
| 2016-06-30 | $240 |
| 2016-03-31 | $264 |
| 2015-12-31 | $238 |
| 2015-09-30 | $209 |
| 2015-06-30 | $184 |
| 2015-03-31 | $213 |
| 2014-12-31 | $197 |
| 2014-09-30 | $194 |
| 2014-06-30 | $170 |
| 2014-03-31 | $184 |
| 2013-12-31 | $164 |
| 2013-09-30 | $155 |
| 2013-06-30 | $147 |
| 2013-03-31 | $178 |
| 2012-12-31 | $153 |
| 2012-09-30 | $153 |
| 2012-06-30 | $137 |
| 2012-03-31 | $164 |
| 2011-12-31 | $138 |
| 2011-09-30 | $133 |
| 2011-06-30 | $133 |
| 2011-03-31 | $156 |
| 2010-12-31 | $137 |
| 2010-09-30 | $135 |
| 2010-06-30 | $18 |
| 2010-03-31 | $142 |
| 2009-12-31 | $139 |
| 2009-09-30 | $133 |
| 2009-06-30 | $125 |
| 2009-03-31 | $140 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.603B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.706B | 24.73 |
| Intuitive Surgical (ISRG) | United States | $193.352B | 101.09 |
| Alcon (ALC) | Switzerland | $43.519B | 29.12 |
| Edwards Lifesciences (EW) | United States | $41.599B | 26.42 |
| IQVIA Holdings (IQV) | United States | $36.625B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $35.273B | 41.54 |
| DexCom (DXCM) | United States | $30.978B | 46.65 |
| Waters (WAT) | United States | $22.985B | 33.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.257B | 0.00 |
| Hologic (HOLX) | United States | $17.928B | 19.36 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.368B | 13.72 |
| Sysmex ADR (SSMXY) | Japan | $13.192B | 41.37 |
| Globus Medical (GMED) | United States | $11.424B | 28.93 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.192B | 44.48 |
| Teleflex (TFX) | United States | $9.024B | 14.39 |
| Glaukos (GKOS) | United States | $7.669B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.015B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.655B | 26.38 |
| Veracyte (VCYT) | United States | $3.419B | 102.61 |
| Inari Medical (NARI) | United States | $3.051B | 0.00 |
| TransMedics (TMDX) | United States | $2.857B | 90.57 |
| LivaNova (LIVN) | United Kingdom | $2.839B | 16.39 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.209B | 19.86 |
| Tandem Diabetes Care (TNDM) | United States | $2.135B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.848B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.284B | 0.00 |
| Artivion (AORT) | United States | $1.242B | 82.28 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.901B | 15.31 |
| Paragon 28 (FNA) | United States | $0.864B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.738B | 0.00 |
| IRadimed (IRMD) | United States | $0.682B | 36.87 |
| Mesa Laboratories (MLAB) | United States | $0.660B | 15.55 |
| AxoGen (AXGN) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.561B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.503B | 29.61 |
| Tactile Systems Technology (TCMD) | United States | $0.446B | 24.14 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.241B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.160B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.140B | 15.02 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.100B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |